Applied Biosystems, now part of Invitrogen, was the first to pioneer a sequencing-by-ligation process, marketing it under the name of SOLiD. The process has some interesting features and is the ...

Applied Biosystems has announced the worldwide commercial availability of SOLiD, the company’s next-generation DNA sequencing platform, which is expected to simplify the identification ...

Applied Biosystems' SOLiD system 1 is a commonly used massively parallel DNA sequencing platform for applications from genotyping and structural variation analysis 1 to transcriptome ...

There's always a new trendy diet plan. But how effective is meal sequencing, actually? Nutrition experts explain.

Their findings, published in the Proceedings of the National Academy of Sciences, pave the way for solid-state, label-free DNA sequencing technologies with implications for precision medicine.

Cancer cell monitoring startup Altum Sequencing has developed a tool that uses a simple blood sample for monitoring treatment response in individuals with solid tumours. The company is based in ...

Scientists at the University of Michigan wanted to understand what makes solid tumors spread—and, by extension, how the growing selection of personalized drugs could best be employed in patients ...

Clinical genomic sequencing is feasible in pediatric oncology and can be used to recommend therapy or pinpoint diagnosis in children with solid tumors, according to the multi-center study.

In 2008, Agencourt Personal Genomics (SOLiD sequencing) was acquired by Applied Biosystems, which then merged with Invitrogen to form Life Technologies.

Clinical genomic sequencing is feasible in pediatric oncology and can be used to recommend therapy or pinpoint diagnosis in children with solid tumors, according to the multicenter Individualized ...

Their findings, published in the Proceedings of the National Academy of Sciences, pave the way for solid-state, label-free DNA sequencing technologies with implications for precision medicine.